Dysfunctional neural regulation of lacrimal gland secretion and its role in the pathogenesis of dry eye syndromes

Ocular Surface

Volumn 2, Issue 2, 2004, Pages 76-91

  Dartt, Darlene A ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

Aging; Dry eye; Epidermal growth factor; Lacrimal gland innervation; Neural dysfunction; Neural regulation of lacrimal gland secretion; Refractive surgery

Indexed keywords

4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; ACETYLCHOLINE; ADENYLATE CYCLASE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA INTERMEDIN; ATROPINE; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; CIRAZOLINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; DIACYLGLYCEROL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EPIDERMAL GROWTH FACTOR RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MUSCARINIC M3 RECEPTOR; MUSCARINIC M3 RECEPTOR ANTAGONIST; NORADRENALIN; PHENYLEPHRINE; PHOSPHOLIPASE C; PHOSPHOLIPASE D; PROTEIN KINASE C; TRANSFORMING GROWTH FACTOR ALPHA; TRIPHOSPHOINOSITIDE; UNINDEXED DRUG; WATER;

AGING; AUTOIMMUNE DISEASE; CORNEA DISEASE; DRUG RECEPTOR BINDING; DRY EYE; ELECTROLYTE TRANSPORT; EYE DISEASE; HUMAN; LACRIMAL FLUID; LACRIMAL GLAND; LACRIMATION; NEUROPATHY; NONHUMAN; PATHOGENESIS; PROTEIN PROTEIN INTERACTION; REFLEX ARC; REFRACTIVE SURGERY; REGULATORY MECHANISM; REVIEW; SENSORY NERVE; SIGNAL TRANSDUCTION; SJOEGREN SYNDROME; TEAR FILM;

EID: 13944257516     PISSN: 15420124     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1542-0124(12)70146-5     Document Type: Review

References (132)

1. Botelho SY. Tears and the lacrimal gland. Sci Am 1964;211:78-86
2. Stern ME, Beuerman RW, Fox RI, et al. The pathology of dry eye:the interaction between the ocular surface and lacrimal glands. Cornea 1998;17:584-9
3. Mathers WD. Why the eye becomes dry:a cornea and lacrimal gland feedback model. CLAO J 2000;26:159-65
4. Acosta MC, Tan ME, Belmonte C, Gallar J. Sensations evoked by selective mechanical, chemical, and thermal stimulation of the conjunctiva and cornea. Invest Ophthalmol Vis Sci 2001;42:2063-7
5. Kelleher S, Hann LE, Edwards JA, Sullivan DA. Endocrine, neural, and immune control of secretory component output by lacrimal gland acinar cells. J Immunol 1991;146:3405-32
6. Schechter JD, Stevenson D, Chang N, et al. Growth of purified lacrimal acinar cells in Matrigel raft cultures. Exp Eye Res 2002;74:349-60
7. Lemp MA. Report of the National Eye Institute/Industry work-shop on Clinical Trials in Dry Eyes. CLAO J 1995;21:221-32
8. Ehinger B. Distribution of adrenergic nerves in the eye and some related structures in the cat. Acta Physiol Scand 1966;66:123-8
9. Powell CC, Martin CL. Distribution of cholinergic and adrenergic nerve fibers in the lacrimal glands of dogs. Am J Vet Res 1989;50:2084-8
10. Ding C, Walcott B, Keyser KT. Neuronal nitric oxide synthase and the autonomic innervation of the mouse lacrimal gland. Invest Ophthalmol Vis Sci 2001;42:2789-94
11. Botelho SY, Hisada M, Fuenmayor N. Functional innervation of the lacrimal gland in the cat. Origin of secretomotor fibers in the lacrimal nerve. Arch Ophthalmol 1966;76:581-8
12. Nikkinen A, Lehtosalo JI, Uusitalo H, et al. The lacrimal glands of the rat and the guinea pig are innervated by nerve fibers containing immunoreactivities for substance P and vasoactive intestinal polypeptide. Histochemistry 1984;81:23-7
13. Zoukhri D, Hodges RR, Dartt DA. Lacrimal gland innervation is not altered with the onset and progression of disease in a murine model of Sjogren's syndrome. Clin Immunol Immunopathol 1998;89:26-33
14. Williams RM, Bauce L, Lea RW, et al. Secretion and serotonin release in the isolated rat lacrimal gland: the effects of substance P and calcitonin gene-related peptide. J Auton Nerv Syst 1996;61:37-42
15. Dartt DA. Signal transduction and control of lacrimal gland protein secretion: a review. Curr Eye Res 1989;8:619-36
16. Hodges RR, Dartt DA. Regulatory pathways in lacrimal gland epithelium. Int Rev Cytol 2003;231:129-96
17. Mauduit P, Jammes H, Rossignol B. M3 muscarinic acetylcholine receptor coupling to PLC in rat exorbital lacrimal acinar cells. Am J Physiol 1993;264(6 Pt 1):C1550-60
18. Qian L, Yang T, Chen H, et al. Heterotrimeric GTP-binding proteins in the lacrimal acinar cell endomembrane system. Exp Eye Res 2002;74:7-22
19. Meneray MA, Fields TY, Bennett DJ. Gs and Gq/11 couple vasoactive intestinal peptide and cholinergic stimulation to lacrimal secretion. Invest Ophthalmol Vis Sci 1997;38:1261-70
20. Godfrey PP, Putney JW Jr. Receptor-mediated metabolism of the phosphoinositides and phosphatidic acid in rat lacrimal acinar cells. Biochem J 1984;218:187-95
21. Dartt DA, Dicker DM, Ronco LV, et al. Lacrimal gland inositol trisphosphate isomer and inositol tetrakisphosphate production. Am J Physiol 1990;259(2 Pt 1):G274-8.
22. Irvine F. 'Quantal' Ca2+ release and the control of Ca2+ entry by inositol phosphates - a possible mechanism. FEBS Lett 1990;263):5-9
23. Bird GS, Obie JF,. Putney JW Jr. Sustained Ca2+ signaling in mouse lacrimal acinar cells due to photolysis of "caged" glycerophosphoryl-myo-inositol 4,5-bisphosphate. J Biol Chem 1992;267:17722-5
24. Berridge MJ. Capacitative calcium entry. Biochem J 1995;312 (Pt 1)1-11
25. Putney JW Jr. Capacitative calcium entry in the nervous system. Cell Calcium 2003;34(4-5):339-44
26. Broad LM, Braun FJ, Lievremont JP, et al. Role of the phospholipase C-inositol 1,4,5-trisphosphate pathway in calcium release-activated calcium current and capacitative calcium entry. J Biol Chem 2001;276:15945-52
27. Dartt DA. Regulation of inositol phosphates, calcium, and protein kinase C in the lacrimal gland. Prog Retin Eye Res 1994;13443-77
28. Mircheff AK. Lacrimal fluid and electrolyte secretion: a review. Curr Eye Res 1989;8:607-17
29. Walcott B. The lacrimal gland and its veil of tears. News Physiol Sci 1998;1397-103
30. Walcott B, Moore L, Birzgalis A, et al. A model of fluid secretion by the acinar cells of the mouse lacrimal gland. Adv Exp Med Biol 2002;506(Pt A):191-7
31. Zoukhri RR, Hodges RR, Willett S, Dartt DA. Immunolocalization of lacrimal gland PKC isoforms. Effect of phorbol esters and cholinergic agonists on their cellular distribution. J Membr Biol 1997;157:169-75
32. Zoukhri D, Hodges RR, Sergheraert C, et al. Lacrimal gland PKC isoforms are differentially involved in agonist-induced protein secretion. Am J Physiol 1997;272(1 Pt 1):C263-9
33. Zoukhri D, Hodges RR, Sergheraert C, Dartt DA. Cholinergic-induced Ca2+ elevation in rat lacrimal gland acini is negatively modulated by PKCdelta and PKCepsilon. Invest Ophthalmol Vis Sci 2000;41:386-92
34. Zoukhri D, Dartt DA. Cholinergic activation of phospholipase D in lacrimal gland acini is independent of protein kinase C and calcium. Am J Physiol 1995;268(3 Pt 1):C713-20
35. Robin P, Rossignol B, Raymond MN. Effect of microtubule network disturbance by nocodazole and docetaxel (Taxotere) on protein secretion in rat extraorbital lacrimal and parotid glands. Eur J Cell Biol 1995;67:227-37
36. da Costa SR, Yarber FA, Zhang L, et al. Microtubules facilitate the stimulated secretion of beta-hexosaminidase in lacrimal acinar cells. J Cell Sci 1998;111( Pt 9):1267-76
37. Wang Y, Jerdeva G, Yarber FA, et al. Cytoplasmic dynein participates in apically targeted stimulated secretory traffic in primary rabbit lacrimal acinar epithelial cells. J Cell Sci 2003;116(Pt 10):2051-65
38. Muallem S, Kwiatkowska K, Xu X, Yin HL. Actin filament disassembly is a sufficient final trigger for exocytosis in nonexcitable cells. J Cell Biol 1995;128(4):589-98
39. Qian L, Wang Y, Xie J, et al. Biochemical changes contributing to functional quiescence in lacrimal gland acinar cells after chronic ex vivo exposure to a muscarinic agonist. Scand J Immunol 2003;58:550-65
40. Meneray MA, Fields TY. Adrenergic stimulation of lacrimal protein secretion is mediated by G(q/11)alpha and G(s)alpha. Curr Eye Res 2000;21:602-7
41. Hodges RR, Dicker DM, Rose PE, Dartt DA. Alpha 1-adrenergic and cholinergic agonists use separate signal transduction pathways in lacrimal gland. Am J Physiol 1992;262(6 Pt 1):G1087-9.
42. Walcott B, Matthews G, Brink P. Differences in stimulus induced calcium increases in lacrimal gland acinar cells from normal and NZB/NZW F1 female mice. Curr Eye Res 2002;25:253-60
43. Gromada J, Jorgensen TD, Dissing S. Cyclic ADP-ribose and inositol 1,4,5-triphosphate mobilizes Ca2+ from distinct intracellular pools in permeabilized lacrimal acinar cells. FEBS Lett 1995;360:303-6
44. Hodges RR, Zoukhri D, Sergheraert C, et al. Identification of vasoactive intestinal peptide receptor subtypes in the lacrimal gland and their signal-transducing components. Invest Ophthalmol Vis Sci 1997;38:610-9
45. Bradley M, Peters C, Lambert R, et al. Subcellular distribution of muscarinic acetylcholine receptors in rat exorbital lacrimal gland. Invest Ophthalmol Vis Sci 1990;31:977-86
46. Yang T, Zeng H, Zhang J, et al. Stimulation with carbachol alters endomembrane distribution and plasma membrane expression of intracellular proteins in lacrimal acinar cells. Exp Eye Res 1999;69:651-61
47. Sundermeier T, Matthews G, Brink PR, Walcott B. Calcium dependence of exocytosis in lacrimal gland acinar cells. Am J Physiol Cell Physiol 2002;282:C360-5
48. Jahn R, Padel U, Porsch PH, Soling HD. Adrenocorticotropic hormone and alpha-melanocyte-stimulating hormone induce secretion and protein phosphorylation in the rat lacrimal gland by activation of a cAMP-dependent pathway. Eur J Biochem. 1982;126:623-9
49. Botelho SY, Martinez EV, Pholpramool C, et al. Modification of stimulated lacrimal gland flow by sympathetic nerve impulses in rabbit. Am J Physiol 1976;230:80-4
50. Kiechle FL, Malinski T. Nitric oxide. biochemistry, pathophysiology, and detection. Am J Clin Pathol 1993;100:567-75
51. Cheng SB, Kuchiiwa S, Kuchiiwa T, et al. Presence of neuronal nitric oxide synthase in autonomic and sensory ganglion neurons innervating the lacrimal glands of the cavan immunofluorescent and retrograde tracer double-labeling study. J Chem Neuroanat 2001;22:147-55
52. Beauregard C, Brandt PC, Chiou GC. Nitric oxide and cyclic GMP-mediated protein secretion from cultured lacrimal gland acinar cells. J Ocul Pharmacol Ther 2002;18:429-43
53. Looms DK, Tritsaris K, Dissing S. Nitric oxide-induced signalling in rat lacrimal acinar cells. Acta Physiol Scand 2002;174:109-15
54. Yoshino K. Monroy D, Pflugfelder SC. Cholinergic stimulation of lactoferrin and epidermal growth factor secretion by the human lacrimal gland. Cornea 1996;15:617-21
55. Massague J, Pandiella A. Membrane-anchored growth factors. Amm Rev Biochem 1993;62:515-41
56. Le Gall SM, Auger R, Dreux C, Mauduit P. Regulated cell surface pro-EGF ectodomain shedding is a zinc metalloprotease-dependent process. J Biol Chem 2003;278:45255-68
57. Marechal H, Jammes H, Rossignol B, Mauduit P. EGF precursor mRNA and membrane-associated EGF precursor protein in rat exorbital lacrimal gland. Am J Physiol Cell Physiol 1999;276:C734-46
58. Graus-Porta D, Beerli RR, Daly JM, Hynes NE. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. Embo J 1997;16:1647-55
59. Arango ME, Li P, Komatsu M, et al. Production and localization of Muc4/sialomucin complex and its receptor tyrosine kinase ErbB2 in the rat lacrimal gland. Invest Ophthalmol Vis Sci 2001;42:2749-56
60. Tepavcevic V, Hodges RR, Zoukhri D, Dartt DA. Signal transduction pathways used by EGF to stimulate protein secretion in rat lacrimal gland. Invest Ophthalmol Vis Sci 2003, in press
61. Ota I, Zoukhri D, Hodges RR, et al. Alpha 1-adrenergic and cholinergic agonists activate MAPK by separate mechanisms to inhibit secretion in lacrimal gland. Am J Physiol Cell Physiol 2003;284:C168-78
62. Prenzel N, Zwick E, Daub H, et al. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 1999;402:884-88
63. Hovanesian JA, Shah SS, Maloney RK. Symptoms of dry eye and recurrent erosion syndrome after refractive surgery. J Cataract Refract Surg 2001;27:577-584.
64. Lee JB, Ryu CH, Kim J, et al. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. J Cataract Refract Surg 2000;26:1326-31
65. Yu EY, Leung A, Rao S, Lam DS. Effect of laser in situ keratomileusis on tear stability. Ophthalmology 2000;107:2131-5
66. Ang RT, Dartt DA, Tsubota K. Dry eye after refractive surgery. Curr Opin Ophthalmol 2001;12:318-22
67. Browning AC, Shah S, Dua HS, et al. Alcohol debridement of the corneal epithelium in PRK and LASEK:an electron microscopic study. Invest Ophthalmol Vis Sci 2003;44:510-3
68. Donnenfeld ED, Solomon K, Perry HD, The effect of hinge position on corneal sensation and dry eye after LASIK. Ophthalmology 2003;110:1023-9;discussion 1029-30
69. Kauffmann T, Bodanowitz S, Hesse L, Kroll P. Corneal reinnervation after photorefractive keratectomy and laser in situ keratomileusis:an in vivo study with a confocal videomicroscope. Ger J Ophthalmol 1996;5:508-12
70. Lee BH, McLaren JW, Erie JC, et al. Reinnervation in the cornea after LASIK. Invest Ophthalmol Vis Sci 2002;43:3660-4
71. Tervo T. Moilanen J. In vivo confocal microscopy for evaluation of wound healing following corneal refractive surgery. Prog Retin Eye Res 2003;22:339-58
72. Murphy PJ, Corbett MC, O'Brart DP, et al. Loss and recovery of corneal sensitivity following photorefractive keratectomy for myopia. J Refract Surg 1999;15:38-45
73. Campos M, Hertzog L, Garbus JJ, McDonnell PJ. Corneal sensitivity after photorefractive keratectomy Am J Ophthalmol 1992;114:51-4
74. Kanellopoulos AJ, Pallikaris IG, Donnenfeld ED, et al. Comparison of corneal sensation following photorefractive keratectomy and laser in situ keratomileusis. J Cataract Refract Surg 1997;23:34-8
75. Perez-Santonja JJ, Sakla HE, Cardona C, et al. Corneal sensitivity after photorefractive keratectomy and laser in situ keratomileusis for low myopia. Am J Ophthalmol 1999;127:497-504
76. Aras C, Ozdamar A, Bahcecioglu H, et al. Decreased tear secretion after laser in situ keratomileusis for high myopia. J Refract Surg 2000;16:362-4
77. Kim WS, Kim JS. Change in corneal sensitivity following laser in situ keratomileusis. J Cataract Refract Surg 1999;25:368-73
78. Chuck,RS, Quiros PA, Perez AC, McDonnell PJ. Corneal sensation after laser in situ keratomileusis. J Cataract Refract Surg 2000;26:337-9
79. Linna TU, Vesaluoma MH, Perez-Santonja JJ, et al. Effect of myopic LASIK on corneal sensitivity and morphology of subbasal nerves. Invest Ophthalmol Vis Sci 2000;41:393-7
80. Benitez-del-Castillo JM, del Rio T, Iradier T, et al. Decrease in tear secretion and corneal sensitivity after laser in situ keratomileusis. Cornea 2001;20:30-2
81. Wilson SE. Laser in situ keratomileusis-induced (presumed) neurotrophic epitheliopathy Ophthalmology 2001;108:1082-7
82. Wilson SE, Ambrosio R. Laser in situ keratomileusis-induced neurotrophic epitheliopathy. Am J Ophthalmol 2001;132:405-6
83. Fox RI, Stern M, Michelson P. Update in Sjogren syndrome. Curr Opin Rheumatol 2000;12:391-8
84. Hocevar A, Tomsic M, Praprotnik S, et al. Parasympathetic nervous system dysfunction in primary Sjogren's syndrome. Ann Rheum Dis 2003;62:702-4
85. Jonsson R., Haga HJ, Gordon TP. Current concepts on diagnosis, autoantibodies and therapy in Sjogren's syndrome. Scand J Rheumatol 2000;29:341-8
86. Yamamoto K. Pathogenesis of Sjogren's syndrome. Autoimmun Rev 2003;2:13-8
87. Brennan MT, Sankar V, Leakan RA, et al. Sex steroid hormones in primary Sjogren's syndrome. J Rheumatol 2003;30:1267-71
88. Sullivan DA, Belanger A, Cermak JM, R. et al. Are Women with Sjogren's syndrome androgen-deficient? J Rheumatol 2003;30:2413-9
89. Warren DW. Hormonal influences on the lacrimal gland. Int Ophthalmol Clin 1994;34:19-25
90. Stern ME, Pflugfelder SC. Inflammation in dry eye. Ocular Surface 2004;2:124-130
91. Mircheff AK. Sjogren's syndrome as failed local immunohomeostasis:prospects for cell-base therapy Ocular Surface 2003;1:160-79
92. Zoukhri D, Hodges RR, Rawe IM, Dartt DA. Ca2+ signaling by cholinergic and alpha 1-adrenergic agonists is up-regulated in lacrimal and submandibular glands in a murine model of Sjogren's syndrome. Clin Immunol Immunopathol 1998;89:134-40
93. Ulbricht KU, Schmidt RE, Witte T. Antibodies against alphafodrin in Sjogren's syndrome. Autoimmun Rev 2003;2:109-13
94. Bacman S, Berra A, Sterin-Borda L, Borda E. Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjogren syndrome. Invest Ophthalmol Vis Sci 2001;42:321-7
95. Borda E, Leiros CP, Bacman S, et al. Sjogren autoantibodies modify neonatal cardiac function via M1 muscarinic acetylcholine receptor activation. Int J Cardiol 1999;70:23-32
96. Andonopoulos AP, Christodoulou J, Ballas D, et al. Autonomic cardiovascular neuropathy in Sjogren's syndrome. A controlled study. J Rheumatol 1998;25:2385-8
97. Kovacs L, Torok T, Bari F, et al. Impaired microvascular response to cholinergic stimuli in primary Sjogren's syndrome. Ann Rheum Dis 2000;59:48-53
98. Falkenbach A., Kovacs J, Franke A, et al. Radon therapy for the treatment of rheumatic diseases-review and meta-analysis of controlled clinical trials. Rheumatol Int 2003, in press
99. Barendregt PJ, van den Bent MJ, van Raaij-van den Aarssen VJ, et al. Involvement of the peripheral nervous system in primary Sjogren's syndrome. Ann Rheum Dis 2001;60:876-81
100. Barendregt PJ, van Den Meiracker AH, Markusse HM, et al. Parasympathetic failure does not contribute to ocular dryness in primary Sjogren's; syndrome. Ann Rheum Dis 1999;58:746-50
101. Niemela RK, Hakala M, Huikuri HV Airaksinen KE. Comprehensive study of autonomic function in a population with primary Sjogren's syndrome. No evidence of autonomic involvement. J Rheumatol 2003;30:74-9
102. Tuomimen IS, Konttinen YT, Vesaluoma MH, et al. Corneal innervation and morphology in primary Sjogren's syndrome. Invest Ophthalmol Vis Sci 2003;44:2545-9
103. Sorajja P, Poirier MK, Bundrick JB, Matteson EL. Autonomic failure and proximal skeletal myopathy in a patient with primary Sjogren syndrome. Mayo Clin Proc 1999;74:695-7
104. Zoukhri D. Kublin CL. Impaired neuro transmitter release from lacrimal and salivary gland nerves of a murine model of Sjogren's syndrome. Invest Ophthalmol Vis Sci 2001;42:925-32
105. Zoukhri D, Hodges RR, Byon D, Kublin CL. Role of proinflammatory cytokines in the impaired lacrimation associated with autoimmume xerophthalmia. Invest Ophthalmol Vis Sci 2002;43:1429-36
106. Bacman S, Perez Leiros C, Sterin-Borda L. Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjogren's syndrome. Invest Ophthalmol Vis Sci 1998;39:151-6
107. Bacman SR, Berra A, Sterin-Borda L, Borda ES. Human primary Sjogren's syndrome autoantibodies; as mediators of nitric oxide release coupled to lacrimal gland muscarinic acetylcholine receptors. Curr Eye Res 1998;17:1135-42
108. Beauregard C, Brandt PC, Chiou GC. Induction of nitric oxide synthase and over-production of nitric oxide by interleukinlbeta in cultured lacrimal gland acinar cells. Exp Eye Res 2003;77:109-14
109. Waterman SA, Gordon TP, Rischmueller M. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjogren's syndrome. Arthritis Rheum 2000;43:1647-54
110. Beroukas D, Goodfellow R, Hiscock J, et al. Up-regulation of M3-muscarinic receptors in labial salivary gland acim in primary Sjogren's syndrome. Lab Invest 2002;82:203-10
111. Dawson LJ,. Field EA, Harmer AR, Smith PM. Acetylcholine-evoked calcium mobilization and ion channel activation in human labial gland acinar cells from patients with primary Sjogren's syndrome. Clin Exp Immunol 2001;124:480-5
112. Nguyen KH, Brayer J, Cha S, et al. Evidence for antimuscarinic acetylcholine receptor antibody-mediated secretory dysfunction in nod mice. Arthritis Rheum 2000;43:2297-306
113. Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol 2003;136:318-26
114. Mathers WD, JA, Zimmerman MB. Tear film changes associated with normal aging. Cornea 1996;15:229-34
115. Patel,S, Farrell J, Bevan R. Relation between precomeal tear film stability and tear production rate in normal eyes. Optom Vis Sci 1989;66:300-3
116. Millodot M. The influence of age on the sensitivity of the cornea. Invest Ophthalmol Vis Sci 1977;16:240-2
117. Millodot M, Owens H. The influence of age on the fragility of the cornea. Acta Ophthalmol (Copenh) 1984;62:819-24
118. Kotulak JC, Brungardt T. Age-related changes in the cornea. J Am Optom Assoc 1980;51:761-5
119. Damato BE, Allan D, Murray SB, Lee WR. Senile atrophy of the human lacrimal gland:the contribution of chronic inflammatory disease. Br J Ophthalmol 1984;68:674-80
120. Obata H, Yamamoto S, Horiuchi H, Machinami R. Histopathologic study of human lacrimal gland. Statistical analysis with special reference to aging. Ophthalmology 1995;102:678-86
121. Gudmundsson OG, Benediktsson H, Olafsdottir K. T-lymphocyte subsets in the human lacrimal gland. Acta Ophthalmol (Copenh) 1988;66:19-23
122. Draper CE, Adeghate E, Lawrence PA, et al. Age-related changes in morphology and secretory responses of male rat lacrimal gland. J Anton Nerv Syst 1998;69(2-3):173-83
123. Draper CE, Adeghate EA, Singh J, Pallot DJ. Evidence to suggest morphological and physiological alterations of lacrimal gland acini with ageing. Exp Eye Res 1999;68:265-76
124. Williams RM, Singh J, Sharkey KA. Innervation and mast cells of the rat exorbital lacrimal gland:the effects of age. J Auton Nerv Syst 1994;47(1-2):95-108
125. Bromberg BB, Welch MH. Lacrimal protein secretion: comparison of young and old rats. Exp Eye Res 1985;40:313-20
126. Bromberg BB, Cripps MM, Welch MH. Sympathomimetic protein secretion by young and aged lacrimal gland. Curr Eye Res 1986;5:217-23
127. van Setten GB, Tervo T, Viinikka L, et al. Ocular disease leads to decreased concentrations of epidermal growth factor in the tear fluid. Curr Eye Res 1991;10:523-7
128. Pffugfelder SC, Jones D, Ji Z, et al. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjogren's syndrome keratoconjunctivitis sicca. Curr Eye Res 1999;19:201-11
129. Ohashi Y, Ishida R, Kojima T, et al. Abnormal protein profiles in tears with dry eye syndrome. Am J Ophthalmol 2003;136:291-9
130. Nava A, Barton K, Monroy DC, Pflugfelder SC. The effects of age, gender, and fluid dynamics on the concentration of tear film epidermal growth factor. Cornea 1997;16:430-8
131. Wilson SE, Liang Q, Kim WJ. Lacrimal gland HGF, KGF, and EGF mRNA levels increase after corneal epithelial wounding. Invest Ophthalmol Vis Sci 1999;40:2185-90
132. Sheardown H, Cheng YL. Tear EGF concentration following corneal epithelial wound creation. J Ocul Pharmacol Ther 1996;12:239-43